Comparative in vitro-in vivo study of two quinine rectal gel formulations

被引:33
作者
Fawaz, F
Koffi, A
Guyot, M
Millet, P
机构
[1] Univ Victor Segalen Bordeaux 2, EA 3677, Lab Pharm Galen & Biopharm, F-33076 Bordeaux, France
[2] Univ Victor Segalen Bordeaux 2, EA 3677, Lab Parasitol & Immunol, F-33076 Bordeaux, France
关键词
bioavailability; hydroxypropyl methylcellulose; malaria; paediatric; poloxamer; quinine pharmacokinetics; rectal gels;
D O I
10.1016/j.ijpharm.2004.05.002
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The main objective of this work was to develop and evaluate rectal quinine paediatric formulations to treat acute uncomplicated malaria attack in some African countries. Developed dosage forms must be able to assure a prolonged release in the rectum but not too much so as to avoid product expulsion by the child anus. Two quinine rectal gels, namely mucoadhesive (MA) gel and thermosensitive (TS) gel, containing 20 mg quinine base/g were developed and evaluated in vitro and in vivo in the rabbit. The MA and the TS gels contained hydroxypropyl methylcellulose 4000 (HPMC) and poloxamer 407, respectively. The calculated in vitro release exponent (n) values suggested that drug was released from both gels by non-Fickian diffusion. Both gels exhibit practically similar efficient of dissolution (ED%) which was not reflected in the plasma and, therefore, quinine bioavailability from MA gel was found to be higher than that obtained from TS gel and their AUC(0-infinity) were statistically different (P = 0.0006). The t(1/2) values of quinine were significantly higher for Hydrogels than for IV and rectal solutions. MRT values displayed by TS gel and MA gel were not statistically different but were about 3.8- and 1.3-fold, respectively, larger than those obtained for IV solution and rectal solution, respectively. These results confirm the sustained-release behaviour of both hydrogels in the rabbit. Tolerability study of hydrogels didn't show any damage on the rectal mucosa of the rabbit. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:151 / 162
页数:12
相关论文
共 35 条
  • [1] Barennes H, 1999, B SOC PATHOL EXOT, V92, P33
  • [2] Barennes H, 1999, Med Trop (Mars), V59, P383
  • [3] Barennes H., 1998, Medecine d'Afrique Noire, V45, P251
  • [4] Intrarectal Quinimax(R) (a combination of cinchona alkaloids) administered at 3 different dosages to children with Plasmodium falciparum malaria in Niger
    Barennes, H
    Pussard, E
    Sani, AM
    Clavier, F
    Henzel, D
    Kahiatani, F
    Granic, G
    Ravinet, L
    Verdier, F
    [J]. CLINICAL DRUG INVESTIGATION, 1996, 11 (03) : 154 - 158
  • [5] INTRARECTAL QUINIMAX(R) (AN ASSOCIATION OF CINCHONA ALKALOIDS) FOR THE TREATMENT OF PLASMODIUM-FALCIPARUM MALARIA IN CHILDREN IN NIGER - EFFICACY AND PHARMACOKINETICS
    BARENNES, H
    KAHIATANI, F
    PUSSARD, E
    CLAVIER, F
    MEYNARD, D
    NJIFOUNTAWOUO, S
    VERDIER, F
    [J]. TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1995, 89 (04) : 418 - 421
  • [6] Efficacy and pharmacokinetics of a new intrarectal quinine formulation in children with Plasmodium falciparum malaria
    Barennes, H
    Pussard, E
    Sani, AM
    Clavier, F
    Kahiatani, F
    Granic, G
    Henzel, D
    Ravinet, L
    Verdier, F
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 41 (05) : 389 - 395
  • [7] NEUROLOGICAL SEQUELAE OF CEREBRAL MALARIA IN CHILDREN
    BREWSTER, DR
    KWIATKOWSKI, D
    WHITE, NJ
    [J]. LANCET, 1990, 336 (8722) : 1039 - 1043
  • [8] MALARIA IN AFRICAN INFANTS AND CHILDREN IN SOUTHERN NIGERIA
    BRUCECHWATT, LJ
    [J]. ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY, 1952, 46 (02): : 173 - 200
  • [9] Development of in situ gelling and mucoadhesive acetaminophen liquid suppository
    Choi, HG
    Jung, JH
    Ryu, JM
    Yoon, SJ
    Oh, YK
    Kim, CK
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1998, 165 (01) : 33 - 44
  • [10] In situ gelling and mucoadhesive liquid suppository containing acetaminophen: enhanced bioavailability
    Choi, HG
    Oh, YK
    Kim, CK
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1998, 165 (01) : 23 - 32